ES2176877T3 - Derivados de tetrazol como antagonistas de ltd4 y h1. - Google Patents

Derivados de tetrazol como antagonistas de ltd4 y h1.

Info

Publication number
ES2176877T3
ES2176877T3 ES98118064T ES98118064T ES2176877T3 ES 2176877 T3 ES2176877 T3 ES 2176877T3 ES 98118064 T ES98118064 T ES 98118064T ES 98118064 T ES98118064 T ES 98118064T ES 2176877 T3 ES2176877 T3 ES 2176877T3
Authority
ES
Spain
Prior art keywords
group
substituted
tetrazol
activity
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98118064T
Other languages
English (en)
Inventor
Hendrik Timmerman
Mingqiang Zang
Kazuhiro Onogi
Takeo Deushi
Masahiro Tamura
Tsutomu Tohma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Application granted granted Critical
Publication of ES2176877T3 publication Critical patent/ES2176877T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Die Bonding (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN DERIVADO DE TETRAZOL REPRESENTADO MEDIANTE LA SIGUIENTE FORMULA (1) O A UNA SAL DEL MISMO: DONDE R 1 Y R 2 REPRESENTAN INDEPENDIENTEMENTE UN ATOMO DE HIDROGENO, UN GRUPO HIDROXILO, UN GRUPO ALQUILO INFERIOR, UN GRUPO ALCOXI SUSTITUIDO O SIN SUSTITUIR, O UN GRUPO ALCANOILOXI SUSTITUIDO O SIN SUSTITUIR; R 3 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO INFERIOR SUSITUIDO O SIN SUSTITUIR; A REPRESENTA UN GRUPO METILENOXI O VINILENO; B REPRESENTA UN GRUPO BENCIMIDAZOLIL SUSTITUIDO O SIN SUSTITUIR; Y UNA LINEA DISCONTINUA PUEDE SER UN ENLACE DOBLE. SE DESCRIBE ASIMISMO UN MEDICAMENTO QUE INCLUYE DICHO DERIVADO COMO INGREDIENTE ACTIVO. EL MEDICAMENTO SEGUN LA INVENCION ESTA DOTADO DE UNA ACTIVIDAD ANTILEUCOTRIENO EXCELENTE Y DE ACTIVIDAD ANTIHISTAMINICA, Y ES UTIL PARA LA PREVENCION Y TRATAMIENTO DE, POR EJEMPLO, ASMA.
ES98118064T 1997-09-26 1998-09-23 Derivados de tetrazol como antagonistas de ltd4 y h1. Expired - Lifetime ES2176877T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26235697 1997-09-26

Publications (1)

Publication Number Publication Date
ES2176877T3 true ES2176877T3 (es) 2002-12-01

Family

ID=17374614

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98118064T Expired - Lifetime ES2176877T3 (es) 1997-09-26 1998-09-23 Derivados de tetrazol como antagonistas de ltd4 y h1.

Country Status (6)

Country Link
US (2) US6121286A (es)
EP (1) EP0905133B1 (es)
KR (1) KR100547506B1 (es)
AT (1) ATE216698T1 (es)
DE (1) DE69805033T2 (es)
ES (1) ES2176877T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957100B1 (en) * 1997-07-07 2004-10-27 Kowa Co., Ltd. Diamine derivatives and pharmaceutical containing the same
EP1188747B1 (en) * 1999-05-24 2005-09-07 Mitsubishi Pharma Corporation Phenoxypropylamine compounds
WO2003000685A1 (fr) * 2001-06-20 2003-01-03 Takeda Chemical Industries, Ltd. Derives heterocycliques a 5 chainons
US7148248B2 (en) 2002-11-29 2006-12-12 Masako Nozaki Method of treating or inhibiting the development of brain inflammation and sepsis
EP1424101A3 (en) * 2002-11-29 2004-08-18 NOZAKI, Masako Use of a leukotriene C4 and D4 receptor antagonist for the preparation of a medicament for treating or preventing brain inflammation and sepsis
CN101022796B (zh) 2004-07-14 2013-02-27 炎症研究中心有限公司 抑制肿瘤转移的方法
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
US8507385B2 (en) * 2008-05-05 2013-08-13 Shanghai Lexvu Opto Microelectronics Technology Co., Ltd. Method for processing a thin film micro device on a substrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
US5756518A (en) * 1996-04-02 1998-05-26 Kowa Co., Ltd. Phenylene derivatives
EP0957100B1 (en) * 1997-07-07 2004-10-27 Kowa Co., Ltd. Diamine derivatives and pharmaceutical containing the same

Also Published As

Publication number Publication date
KR19990030070A (ko) 1999-04-26
EP0905133A1 (en) 1999-03-31
KR100547506B1 (ko) 2006-06-22
ATE216698T1 (de) 2002-05-15
US6121286A (en) 2000-09-19
DE69805033D1 (de) 2002-05-29
EP0905133B1 (en) 2002-04-24
US6117886A (en) 2000-09-12
DE69805033T2 (de) 2002-11-14

Similar Documents

Publication Publication Date Title
ES2193208T3 (es) Nuevos derivados de quinuclidina y composicion farmaceutica que los contiene.
PA8442201A1 (es) Derivados de 6-fenilpiridil-2-amina
ES2171416T3 (es) Remedio contra la trombocitopenia.
ES2097872T3 (es) Fenilpirazolidinonas como agentes broncodilatadores y antiinflamatorios.
ES2142000T3 (es) Derivados del acido metoxiiminoacetico y fungicidas agricolas y horticolas que los contienen como ingrediente activo.
BR0207025A (pt) Derivado de isoxazolina e herbicida contendo o mesmo como o ingrediente ativo
MA32232B1 (fr) Nouveaux compoés hétérocycliques et leurs utilisations
CO4130325A1 (es) Nuevos derivados herbicidas de 2-ciano-1,3-diona, procedi- mientos para su preparacion y composiciones que los contie- nen
MY124280A (en) Enhancer for agricultural chemicals, enhancer composition for agricultural chemicals and method for enhancing the efficacy of agricultural chemical
BR9811093A (pt) Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo)
PL350123A1 (en) Tetrahydropyran derivatives and their use as therapeutic agents
ES2152016T3 (es) Solucion oftalmica de pranoprofeno conteniendo amina organica.
ES2151698T3 (es) Nuevos derivados de 6-hidroxi y 6-oxo-androstan activos sobre el sistema cardiovascular y composiciones farmaceuticas que los contienen.
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
ES2175386T3 (es) Derivados de 2,3-benzodiazepina y su utilizacion como inhibidores de receptores de ampa.
BR9908301A (pt) Derivados de indol e composições farmacêuticas que compreendem os mesmos
PA8487701A1 (es) Derivados de 3,3-biarilpiperidina y 2,2-biarilmorfolina
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
AR027578A1 (es) Derivados de indano
ES2161439T3 (es) Derivados triterpenicos medicamentos para enfermedades hepaticas.
AR032230A1 (es) Derivado sulfonamida conteniendo una composicion agricola y horticola
EP1374868A4 (en) MEDICAMENT FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC ISCHEMIC DISEASES
DE69805860D1 (de) Wasserlösliche ähnliche verbindungen und medicament-vorstufe von paclitaxel
ES2058085T3 (es) Composicion anticonvulsivante que contiene un derivado de aminoacido, y utilizacion de dicho derivado de aminoacido.
BR0211025A (pt) Um novo composto para o tratamento da impotência